Precigen Ownership | Who Owns Precigen?
Precigen Ownership Summary
Precigen is owned by 27.65% institutional investors, 10.46% insiders, and 61.89% retail investors. Patient capital management is the largest institutional shareholder, holding 5.49% of PGEN shares. Patient Opportunity C is the top mutual fund, with 4.34% of its assets in Precigen shares.
PGEN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Precigen | 27.65% | 10.46% | 61.89% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Patient capital management | 16.27M | 5.49% | $23.10M |
| Blackrock | 10.25M | 4.11% | $16.19M |
| Adage capital partners gp | 11.28M | 3.80% | $16.01M |
| Blackrock funding, inc. /de | 11.15M | 3.76% | $15.83M |
| Vanguard group | 8.33M | 3.02% | $9.33M |
| Iridian asset management llc/ct | 4.28M | 1.44% | $6.08M |
| Geode capital management | 3.30M | 1.20% | $3.70M |
| State street | 2.84M | 1.14% | $4.49M |
| Parkman healthcare partners | 1.54M | 0.52% | $2.19M |
| Charles schwab investment management | 1.28M | 0.46% | $1.43M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Iridian asset management llc/ct | 4.28M | 2.10% | $6.08M |
| Patient capital management | 16.27M | 1.04% | $23.10M |
| Emfo | 519.48K | 0.73% | $820.77K |
| Diametric capital, lp | 335.06K | 0.25% | $475.78K |
| Parkman healthcare partners | 1.54M | 0.25% | $2.19M |
| Fore capital | 341.81K | 0.17% | $485.37K |
| Lexaurum advisors | 672.54K | 0.15% | $955.01K |
| Clarivest asset management | 492.15K | 0.08% | $777.60K |
| Stoneridge investment partners | 68.68K | 0.07% | $98.00K |
| Inspire investing | 275.87K | 0.04% | $391.74K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Susquehanna group, llp | 704.89K | 0.00% | 655.11K |
| Blackrock funding, inc. /de | 11.15M | 0.00% | 393.29K |
| Marshall wace, llp | 369.14K | 0.00% | 369.14K |
| Diametric capital, lp | 335.06K | 0.25% | 335.06K |
| Ubs group | 421.24K | 0.00% | 321.72K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Parkman healthcare partners | 1.54M | 0.25% | -1.65M |
| Patient capital management | 16.27M | 1.04% | -1.10M |
| Opaleye management | - | - | -947.50K |
| D. e. shaw | 424.90K | 0.00% | -792.73K |
| Renaissance | 1.07M | 0.00% | -532.54K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Marshall wace, llp | 369.14K | 0.00% | 369.14K | $524.18K |
| Diametric capital, lp | 335.06K | 0.25% | 335.06K | $475.78K |
| Prelude capital management | 131.09K | 0.02% | 131.09K | $186.15K |
| Group one trading | 68.86K | 0.00% | 68.86K | $77.12M |
| Vanguard personalized indexing management | 29.32K | 0.00% | 29.32K | $32.84K |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -2.00 |
| True wealth design | -20.00 |
| Farther finance advisors | -78.00 |
| Creekmur asset management | -98.00 |
| Innealta capital | -99.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 148 | 4.23% | 81,957,215 | 2.59% | 27 | 3.30% | 64 | 6.67% | 34 | -17.07% |
| Mar 31, 2025 | 141 | 6.01% | 79,994,349 | 5.56% | 28 | 3.84% | 58 | -10.77% | 42 | 44.83% |
| Dec 31, 2024 | 69 | -47.73% | 34,834,421 | -53.82% | 12 | 1.41% | 32 | -40.74% | 13 | -58.06% |
| Sep 30, 2024 | 132 | -2.22% | 75,430,370 | 24.15% | 29 | 5.16% | 54 | -6.90% | 31 | -20.51% |
| Jun 30, 2024 | 133 | -0.75% | 60,750,666 | -1.85% | 24 | 3.95% | 58 | 26.09% | 39 | -15.22% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Patient Opportunity C | 12.80M | 4.34% | -800.00K |
| Vanguard US Total Market Shares ETF | 5.45M | 1.85% | - |
| Vanguard Total Stock Mkt Idx Inv | 5.34M | 1.79% | -117.52K |
| iShares Russell 2000 ETF | 3.64M | 1.23% | -69.09K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.62M | 0.54% | -704.57K |
| Fidelity Small Cap Index | 1.38M | 0.47% | - |
| iShares Russell 2000 Growth ETF | 1.27M | 0.43% | - |
| iShares Russell 2000 Value ETF | 1.12M | 0.38% | - |
| iShares Biotechnology ETF | 985.25K | 0.33% | 8.42K |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 868.39K | 0.29% | 4.18K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 04, 2025 | AGEE NANCY H | - | Buy | $69.00K |
| Aug 28, 2025 | AGEE NANCY H | - | Buy | $49.49K |
| Aug 19, 2025 | AGEE NANCY H | - | Buy | $49.15K |
| Dec 30, 2024 | KIRK RANDAL J | Buy | $12.50M | |
| Dec 30, 2024 | KIRK RANDAL J | Buy | $28.13K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | 3 | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | 2 | - |
| 2024 Q3 | 2 | - |
PGEN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools